Litigation

Recent Posts

U.S. High Court Won’t Hear Arguments That Punitives Are Preempted In Drug Cases
Posted on 7 Oct 2013 by Tom Moylan

WASHINGTON, D.C. — (Mealey’s) The U.S. Supreme Court on Oct. 7 refused to hear arguments by Novartis Pharmaceuticals Corp. that federal drug regulations and high court precedent preempt the awarding of state law punitive damages in an Aredia... Read More

$12.8M Verdict For Jaw Injury In Aredia/Zometa Case To Be Reduced To $1.14M
Posted on 24 Nov 2010 by Tom Moylan

WINSTON-SALEM, N.C. - (Mealey's) A North Carolina federal jury on Nov. 22 awarded $12,887,001 in an Aredia/Zometa jaw injury case, a verdict that will be reduced to $1,148,001 by North Carolina's limit on punitive damages ( Herbert Fussman, et... Read More

N.J. Jury Finds Novartis Didn't Fail To Warn About Jaw Risk From Aredia, Zometa Bone Drugs
Posted on 7 Oct 2010 by Tom Moylan

NEW BRUNSWICK, N.J. -- A New Jersey state court jury on Oct. 6 found that Novartis Pharmaceuticals Corp. did not fail to provide adequate warning to a cancer patient's doctor that its bone-saving drugs Aredia and Zometa had a risk of osteonecrosis... Read More

Tennessee Federal Judge Won’t Dismiss Jaw Injury Cases
Posted on 9 Mar 2010 by LexisNexis Litigation Resource Community Staff

NASHVILLE, Tenn. – (AP) A federal judge in Nashville has refused to dismiss 40 lawsuits against a Swedish-based pharmaceutical company accused of failing to warn patients that two of its drugs can cause severe deterioration of the jaw. U.S... Read More